171 related articles for article (PubMed ID: 9394035)
1. Relative contribution of human erythrocyte aldehyde dehydrogenase to the systemic detoxification of the oxazaphosphorines.
Dockham PA; Sreerama L; Sladek NE
Drug Metab Dispos; 1997 Dec; 25(12):1436-41. PubMed ID: 9394035
[TBL] [Abstract][Full Text] [Related]
2. Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde.
Dockham PA; Lee MO; Sladek NE
Biochem Pharmacol; 1992 Jun; 43(11):2453-69. PubMed ID: 1610409
[TBL] [Abstract][Full Text] [Related]
3. Identification of the mouse aldehyde dehydrogenases important in aldophosphamide detoxification.
Manthey CL; Landkamer GJ; Sladek NE
Cancer Res; 1990 Aug; 50(16):4991-5002. PubMed ID: 2379164
[TBL] [Abstract][Full Text] [Related]
4. NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide.
Parekh HK; Sladek NE
Biochem Pharmacol; 1993 Sep; 46(6):1043-52. PubMed ID: 8216347
[TBL] [Abstract][Full Text] [Related]
5. Kinetic characterization of the catalysis of "activated" cyclophosphamide (4-hydroxycyclophosphamide/aldophosphamide) oxidation to carboxyphosphamide by mouse hepatic aldehyde dehydrogenases.
Manthey CL; Sladek NE
Biochem Pharmacol; 1988 Jul; 37(14):2781-90. PubMed ID: 3395357
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
Maki PA; Sladek NE
Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3.
Giorgianni F; Bridson PK; Sorrentino BP; Pohl J; Blakley RL
Biochem Pharmacol; 2000 Aug; 60(3):325-38. PubMed ID: 10856427
[TBL] [Abstract][Full Text] [Related]
8. Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
Sreerama L; Sladek NE
Drug Metab Dispos; 1995 Oct; 23(10):1080-4. PubMed ID: 8654195
[TBL] [Abstract][Full Text] [Related]
9. Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
Sreerama L; Sladek NE
Cancer Res; 1994 Apr; 54(8):2176-85. PubMed ID: 8174125
[TBL] [Abstract][Full Text] [Related]
10. Fluorimetric detection of aldehyde dehydrogenase activity in human blood, saliva, and organ biopsies and kinetic differentiation between class I and class III isozymes.
Wierzchowski J; Wroczynski P; Laszuk K; Interewicz E
Anal Biochem; 1997 Feb; 245(1):69-78. PubMed ID: 9025970
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte aldehyde dehydrogenase and clinical chemical markers of alcohol abuse and alcoholism.
Towell JF; Townsend WF; Kalbfleisch JH; Wang RI; Zablocki CJ
Alcohol Drug Res; 1985-1986; 6(1):15-21. PubMed ID: 4074469
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
Sreerama L; Sladek NE
Biochem Pharmacol; 1993 Jun; 45(12):2487-505. PubMed ID: 8328987
[TBL] [Abstract][Full Text] [Related]
13. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by chlorpropamide analogues.
Rekha GK; Devaraj VR; Sreerama L; Lee MJ; Nagasawa HT; Sladek NE
Biochem Pharmacol; 1998 Feb; 55(4):465-74. PubMed ID: 9514081
[TBL] [Abstract][Full Text] [Related]
15. Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymes.
von Eitzen U; Meier-Tackmann D; Agarwal DP; Goedde HW
Cancer Lett; 1994 Jan; 76(1):45-9. PubMed ID: 8124665
[TBL] [Abstract][Full Text] [Related]
16. Identification of 4-(N,N-dipropylamino)benzaldehyde as a potent, reversible inhibitor of mouse and human class I aldehyde dehydrogenase.
Russo J; Chung S; Contreras K; Lian B; Lorenz J; Stevens D; Trousdell W
Biochem Pharmacol; 1995 Jul; 50(3):399-406. PubMed ID: 7646541
[TBL] [Abstract][Full Text] [Related]
17. Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.
Cox PJ; Phillips BJ; Thomas P
Cancer Treat Rep; 1976 Apr; 60(4):321-6. PubMed ID: 179712
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase.
Rekha GK; Sreerama L; Sladek NE
Biochem Pharmacol; 1994 Nov; 48(10):1943-52. PubMed ID: 7986206
[TBL] [Abstract][Full Text] [Related]
19. Identification of the class-3 aldehyde dehydrogenases present in human MCF-7/0 breast adenocarcinoma cells and normal human breast tissue.
Sreerama L; Sladek NE
Biochem Pharmacol; 1994 Aug; 48(3):617-20. PubMed ID: 8068047
[TBL] [Abstract][Full Text] [Related]
20. Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid.
Lee MO; Manthey CL; Sladek NE
Biochem Pharmacol; 1991 Aug; 42(6):1279-85. PubMed ID: 1888336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
